Payment & Shipping Terms:
|Name:||IGF LR3||Synonyms:||Insulin-Like Growth Factor - I LR3|
|Appearance:||Lyophilized Powder||Unit Size:||1mg/vial Or 0.1mg/vial|
anabolic steroid injections,
growth hormone releasing peptide
Insulin-Like Growth Factor-I LR3 Human Growth Hormone Peptides Powder IGF LR3
|Synonyms||Insulin-Like Growth Factor-I LR3|
|Reports||Certificate of Analysis|
|Packing||Freeze-dried powder in 10ml sterile bottle|
IGF-1 lr3 is also known as Long R3 IGF-1 or Insulin-Like Growth Factor-I Long Arg3, is a polypeptide hormone with properties similar to insulin.This is a human recombinant, single and polypeptide having a molecular mass of 9200 Daltons,it contains 83 amino acids with substitution of Arginine instead of Glutamic acid at position 3. Altered polypeptide sequence prevents protein binding and increases half-life.
The Long R3 IGF-1 version is significantly more potent than regular IGF-1. The enhanced potency is due to the decreased binding of IGF1 LR3 to all known IGF binding proteins.It is approximately 3 times more potent than IGF-1 and possesses an increased half-life due to lowered affinity for binding to the IGFBPs.It is more able to stimulate the type 1 IGF receptor and thus induce a higher level of activation of intracellular signaling, which is responsible for promoting cell proliferation and the inhibition of apoptosis.
IGF-1 LR3 was specifically designed and manufactured for mammalian cell culture to support large-scale manufacturing of recombinant biopharmaceuticals.IGF-1 LR3 allows many growth factors in the category of IGF’s to increase protein formation through nitrogen retention.It is the primary protein involved in responses of cells to growth hormone,produced in response to GH and then induces cellular activities.IGF-1 LR3 has an enhanced potency because of increased binding sites and plays a vital role in muscle renewal,and it encourages the production and differential of stem cells.IGF-1 causes muscle cell hyperplasia, which is an actual splitting and forming of new muscle cells,it is known to increase satellite activity of the cells, muscle protein content, muscle DNA, and muscle cross sectional area and muscle weight.
IGF-1 LR3 can be taken 7 days a week at a dose of 50-150mcg a day. Desensitization was shown to occur at around 40 days or roughly 4 weeks. Injection sites can be at any muscle group on the body, as it’s not very good at site specific growth.
enlarged amino acid transporting cells
increased protein production
reduced protein degradation
amplified glucose transporting
augmented RNA combination
|Email : firstname.lastname@example.org||Skype : tonyself2000|
|51753-57-2||CJC-1295 with DAC||2mg/vial,10vials/kit|
|87616-84-0||CJC-1295 without DAC||2mg/vial,10vials/kit|
|137525-51-0||Pentadecapeptide BPC 157||2mg/vial,10vials/kit|